Hemp Industry questions covered in the episode:
- How will the House Oversight and Reform Committee approach the issue of FDA's inaction on regulating hemp and CBD?
- What will be different about your committee's approach than Congressional efforts over the past several years to demand FDA's action?
- Are challenges with the administrative state mostly political in nature or are they more related to the behavior of entrenched career bureaucrats?
- What will be the other priorities for the committee in 2023?
- Where will there be opportunities for bi-partisan action to promote stronger government agencies?